Vault-ready proton system headed to Tam Anh
Mevion said the S250-FIT installation would be Vietnam’s first proton therapy system, with operation expected as early as late 2027 at Tam Anh’s Phu My Hung facility.
Tam Anh General Hospital is set to receive a MEVION S250-FIT Proton Therapy System under a definitive purchase agreement with Mevion Medical Systems. Mevion said the installation would be the first proton therapy system in Vietnam.
Both the MEVION S250-FIT and MEVION S250i Proton Therapy System have recently received regulatory approval in Vietnam, according to the company. TD Tech Company, Mevion’s distributor in Vietnam, is facilitating the project.
The S250-FIT system at Tam Anh is expected to become operational as early as late 2027. The timeline is tied to the opening of Tam Anh’s new facility in Phu My Hung.
Mevion describes the S250-FIT as a proton therapy system designed for installation in a standard, existing radiation therapy vault. The company said the system will include an upright patient-positioning system from Leo Cancer Care and RayStation treatment-planning software from RaySearch Laboratories.
FDA records list the S250-FIT under 510(k) K250986 as a Class II medical charged-particle radiation therapy system. The device is intended to deliver proton radiation treatment to patients with localized tumors or other conditions susceptible to radiation treatment.
The FDA summary states that fully seated use is indicated for localized tumors and other radiation-treatable conditions at sites above the mid-chest or carina. The agency found the system substantially equivalent to Mevion’s previously cleared S250i device.
Companies:Mevion Medical Systems, Tam Anh General Hospital
Sources
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
Pathology support broadens MedDream viewer scope
Version 8.9.0 is scheduled for June 2026 through aycan and will add support for pathology workflows and saving reconstructed MPR viewports as new study series.
DOSIsoft unit gives PLANET a theranostics focus
DOSIsoft Theranostics will operate within the DOSIsoft group, with its own partnerships and investment strategy centered on PLANET software.
I-MED sale gives Jardines 215-clinic radiology network
Jardine Matheson will acquire 100% of I-MED Radiology Network in a deal valued at A$3.4B, including I-MED’s minority stake in Harrison.ai.
Expected Russell addition puts Hyperfine in small-cap benchmarks
FTSE Russell’s preliminary June reconstitution list includes Hyperfine, with index changes set to take effect after U.S. markets close on June 26.
Curium approach puts Lantheus deal value near $7B
Lantheus is weighing a potential sale after an approach from Curium Pharma, while company filings show recent Pylarify pressure and pending PET regulatory milestones.
Niowave Lansing site to scale Ac-225 supply by 2028
The Lansing, MI, site will house superconducting linear accelerators and radiochemistry systems to support scalable actinium-225 production, with completion expected in 2028.
30-year GE-UW tie expands into CT and theranostics research
The collaboration will focus on CT and molecular imaging technologies for cardiology, oncology, and theranostics workflows at UW Medicine Radiology facilities in Seattle.
Recall issues and isotope shortages weigh on Radnostix Q1 revenue
The radioisotope-focused company reported $2.38M in Q1 revenue, citing recall impacts, isotope shortages, and Cobalt-60 hot cell downtime.
Ephemeral to build AI data platform for Plus CNS oncology programs
The companies will develop an AI platform to integrate therapeutic, diagnostic, and bioinformatics data across Plus Therapeutics’ CNS oncology programs.
Fujifilm balloon-free EBUS scope targets pulmonary setup time
The EB-710US Ultrasound Bronchoscope is designed for pulmonary procedures and will be demonstrated at the American Thoracic Society Conference.
ACIST Pro brings contrast tracking upgrade to U.S. cath labs
The Bracco company received U.S. clearance and launched ACIST Pro, a variable-rate contrast management system for image-guided cardiovascular procedures.
Braid Health launches $199 radiology second-opinion service
Patients can upload MRI, CT, X-ray, or ultrasound files and receive a written second opinion from a board-certified U.S. radiologist.